Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Garidel

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
Journal of Pharmaceutical Sciences|August 24, 2022
Industry Perspective on the Use and Characterization of Polysorbates for Biopharmaceutical Products Part 2: Survey Report on Control Strategy Preparing for the FutureKlaus Wuchner, Linda Yi, Cyrille Chery, et al.
Journal of Pharmaceutical Sciences|April 3, 2015
Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and StrategyLinda O Narhi, Vincent Corvari, Dean C Ripple, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 2, 2015
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysisVincent Corvari, Linda O Narhi, Thomas M Spitznagel, et al.
Mabs|April 4, 2025
Proceedings of the 15<sup>th</sup> European immunogenicity platform open symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Karien Bloem, Lysie Champion, et al.
Journal of Pharmaceutical Sciences|November 22, 2021
An Interlaboratory Comparison on the Characterization of a Sub-micrometer Polydisperse Particle DispersionKurt D Benkstein, Gurusamy Balakrishnan, Ashwinkumar Bhirde, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Journal of Pharmaceutical Sciences|August 24, 2022
Industry Perspective on the Use and Characterization of Polysorbates for Biopharmaceutical Products Part 2: Survey Report on Control Strategy Preparing for the FutureKlaus Wuchner, Linda Yi, Cyrille Chery, et al.
Journal of Pharmaceutical Sciences|April 3, 2015
Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and StrategyLinda O Narhi, Vincent Corvari, Dean C Ripple, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 2, 2015
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysisVincent Corvari, Linda O Narhi, Thomas M Spitznagel, et al.
Mabs|April 4, 2025
Proceedings of the 15<sup>th</sup> European immunogenicity platform open symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Karien Bloem, Lysie Champion, et al.
Journal of Pharmaceutical Sciences|November 22, 2021
An Interlaboratory Comparison on the Characterization of a Sub-micrometer Polydisperse Particle DispersionKurt D Benkstein, Gurusamy Balakrishnan, Ashwinkumar Bhirde, et al.
Pageof 15